Mark Newcomer compensation by year
Paysign Summary Compensation Table · all 5 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2022 | FY2025 |
|---|---|---|---|---|---|
| Salary | $424,188 | $650,000 | $883,333 | $950,000 | $1,050,000 |
| Bonus | $60,000 | $146,400 | $53,600 | $204,149 | $301,865 |
| Stock awards | $63,036 | $63,036 | $63,036 | $1,357,500 | $1,398,000 |
| Option awards | $0 | $0 | $0 | — | $0 |
| Non-equity incentive | $0 | $0 | $0 | — | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | — | $0 |
| All other | $4,500 | $15,500 | $32,000 | $6,588 | $4,400 |
| Total | $551,724 | $874,936 | $1,031,969 | $2,518,237 | $2,754,265 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Paysign, Inc. DEF 14A filed March 26, 2026, accession 0001683168-26-002222, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Paysign, Inc. filed document, accession 0001683168-26-002222. Every figure is read from that document and cited to the page and table it appears in. Filed March 26, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 900,000 | $4,635,000 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Paysign, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
10 Form 4 lines since the FY2025 proxy (filed March 26, 2026)current to 2026-11-07 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-10-09 | Sale | 10b5-1 | 50,000 | $15.34 | 9,113,002 |
| 2026-08-06 | Sale | 10b5-1 | 150,000 | $11.88 | 9,163,002 |
| 2026-07-31 | Exercise or conversion | — | 150,000 | $0.00 | 9,372,027 |
| 2026-07-31 | Tax withholding | — | 59,025 | $8.96 | 9,313,002 |
| 2026-07-31 | Exercise or conversion derivative | — | 150,000 | $0.00 | 150,000 |
| 2026-07-29 | Sale | 10b5-1 | 50,000 | $9.38 | 9,222,027 |
| 2026-05-20 | Tax withholding | — | 78,701 | $6.15 | 9,005,361 |
| 2026-05-20 | Grant or award | — | 133,334 | $0.00 | 9,084,062 |
The 8 most recent of 10 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Paysign’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Mark Newcomer · this page | Chief Executive Officer | $2,754,265 |
| Matthew Turner | President, Patient Affordability | $1,542,526 |
| Michael Ngo | Chief Innovation Officer | $1,489,712 |
Board service
Paysign board · FY2022–FY2025How this board is paid
Company policy: Paysign pays directors a $21,000 cash retainer and $143,200 in Restricted Stock. As stated in Paysign's FY2025 proxy.
The full Paysign compensation record
free company briefThis page is one person within Paysign's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Paysign's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Paysign's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order PAYS
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.